PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
0.17%
Net income growth under 50% of MCHP's 45.79%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
9.17%
D&A growth well above MCHP's 8.32%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
78.57%
Well above MCHP's 155.27% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
-20.00%
Both cut yoy SBC, with MCHP at -8.62%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
126.17%
Less working capital growth vs. MCHP's 497.79%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
137.97%
AR growth well above MCHP's 267.55%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-47.48%
Both reduce yoy inventory, with MCHP at -80.39%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
121.05%
Lower AP growth vs. MCHP's 1578.57%, indicating prompt payments. David Dodd would confirm no lost opportunity in interest-free credit if expansions are underfunded.
227.40%
Growth well above MCHP's 334.18%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
83.24%
Some yoy increase while MCHP is negative at -74.71%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
56.45%
Operating cash flow growth 1.25-1.5x MCHP's 39.51%. Bruce Berkowitz might see better working capital management or consistent margin advantages.
-32.33%
Both yoy lines negative, with MCHP at -15.54%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-100.00%
Both yoy lines negative, with MCHP at -100.00%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
-76.59%
Negative yoy purchasing while MCHP stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-27.79%
We reduce yoy sales while MCHP is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-112.20%
Both yoy lines negative, with MCHP at -31.56%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-272.49%
Both yoy lines negative, with MCHP at -31.56%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-39.00%
We cut debt repayment yoy while MCHP is 13.93%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
39.29%
We slightly raise equity while MCHP is negative at -35.38%. John Neff sees competitor possibly preserving share count or buying back shares.
15.74%
Buyback growth of 15.74% while MCHP is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.